Mammalian organs vary widely in regenerative capacity. Poorly regenerative organs, such as the heart are particularly vulnerable to organ failure. Once established, heart failure commonly results in mortality 1 . The Hippo pathway, a kinase cascade that prevents adult cardiomyocyte proliferation and regeneration 2 , is upregulated in human heart failure. Here we show that deletion of the Hippo pathway component Salvador (Salv) in mouse hearts with established ischaemic heart failure after myocardial infarction induces a reparative genetic program with increased scar border vascularity, reduced fibrosis, and recovery of pumping function compared with controls. Using translating ribosomal affinity purification, we isolate cardiomyocyte-specific translating messenger RNA. Hippo-deficient cardiomyocytes have increased expression of proliferative genes and stress response genes, such as the mitochondrial quality control gene, Park2. Genetic studies indicate that Park2 is essential for heart repair, suggesting a requirement for mitochondrial quality control in regenerating myocardium. Gene therapy with a virus encoding Salv short hairpin RNA improves heart function when delivered at the time of infarct or after ischaemic heart failure following myocardial infarction was established. Our findings indicate that the failing heart has a previously unrecognized reparative capacity involving more than cardiomyocyte renewal.
Mammalian organs vary widely in regenerative capacity. Poorly regenerative organs, such as the heart are particularly vulnerable to organ failure. Once established, heart failure commonly results in mortality 1 . The Hippo pathway, a kinase cascade that prevents adult cardiomyocyte proliferation and regeneration 2 , is upregulated in human heart failure. Here we show that deletion of the Hippo pathway component Salvador (Salv) in mouse hearts with established ischaemic heart failure after myocardial infarction induces a reparative genetic program with increased scar border vascularity, reduced fibrosis, and recovery of pumping function compared with controls. Using translating ribosomal affinity purification, we isolate cardiomyocyte-specific translating messenger RNA. Hippo-deficient cardiomyocytes have increased expression of proliferative genes and stress response genes, such as the mitochondrial quality control gene, Park2. Genetic studies indicate that Park2 is essential for heart repair, suggesting a requirement for mitochondrial quality control in regenerating myocardium. Gene therapy with a virus encoding Salv short hairpin RNA improves heart function when delivered at the time of infarct or after ischaemic heart failure following myocardial infarction was established. Our findings indicate that the failing heart has a previously unrecognized reparative capacity involving more than cardiomyocyte renewal.
Heart failure, the inability of the heart to pump blood, has no defini tive treatment except heart transplantation or ventricular assist device 3 . In heart failure, physiological compensatory mechanisms place strain on cardiomyocytes and promote cardiomyocyte loss and fibrosis in pathological remodelling [4] [5] [6] . Hippo pathway activation, including Mst and Lats kinases and Salv adaptor, results in phosphorylation and nuclear exclusion of transcriptional cofactors Yap and Taz that coope ratively bind DNA with Tead factors 2, 7 . Concurrent Salv or Lats1 and Lats2 deletion with myocardial infarct improves heart function [8] [9] [10] . Yap target genes control proliferation, cytoskeletal remodelling, and protect plasma membrane from contractile stress 9 . Maladaptive activation of Hippo signalling occurs in human heart failure and mouse ischaemia reperfusion 11, 12 . To determine whether endogenous cardiomyocyte renewal can be increased in heart failure, we deleted Salv in a mouse model of ischaemic heart failure after myocardial infarction. The Hippo pathway represses a reparative genetic program in ischaemic heart failure that includes cardiomyocyte proliferation and survival genes.
Western blots on human samples of ischaemic and non ischaemic heart failure revealed that levels of phosphorylated Yap and Lats (pYap and pLats, respectively) at serine 909 were higher and levels of Salv were unchanged in both types of sample compared with controls ( Fig. 1a-f and Extended Data Fig. 1a-c) . We generated αMHCmcm;Salv f/f (conditional knockout of Salv; SalvCKO) mice with ischaemic heart failure after myocardial infarction ( Fig. 2a ). Echocardiography 3 weeks after myocardial infarction before treatment with tamoxifen revealed shams had an average ejection fraction of 64 ± 12% (mean ± s.d.) and fractional shortening of 35 ± 8% ( Fig. 2a-c) . After myocardial infarc tion, mice had an average ejection fraction of 36 ± 11% and fractional shortening of 18 ± 6% ( Fig. 2a-c) 13 . Endsystolic variables showed increased systolic left ventricle chamber diameters (sham 2.7 ± 0.6 mm, myocardial infarction 3.8 ± 0.6 mm) and volumes (sham 29 ± 18 μ l, myocardial infarction 66 ± 43 μ l) (Extended Data Fig. 2a-d ). Diastolic indices were unchanged, indicating ischaemic heart failure was a result of systolic dysfunction (Extended Data Fig. 2b, d ). Other ischaemic heart failure signs included pulmonary fluid buildup, haemosiderinladen macrophages, increased natriuretic peptide B (BNP) serum levels, and increased body weights (Extended Data Fig. 2e -j).
Three weeks after myocardial infarction, we deleted Salv in cardiomyocytes and performed echocardiography every 2 weeks until 9 weeks after myocardial infarction (6 weeks after tamoxifen injection) ( Fig. 2a -c and Extended Data Fig. 2a -d, k, l). At 9 weeks after myo cardial infarction, SalvCKO had improved function (ejection fraction: SalvCKO myocardial infarction 59% ± 13%, control myocardial infarc tion 38 ± 9%, P = 0.001) similar to sham controls (ejection fraction: control and SalvCKO sham 65% ± 8%, P = 1) ( Fig. 2c ).
Control hearts 9 weeks after myocardial infarction had remod elled scars whereas SalvCKO hearts showed less fibrosis and more left 
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ventricle cardiomyocytes (percentage area fibrosis: control 56 ± 12%, SalvCKO 36 ± 15%; cardiomyocyte number: control 1 × 10 5 ± 8 × 10 4 , SalvCKO 6 × 10 5 ± 2 × 10 5 ) ( Fig. 2d -j). We defined three qualitative categories of damage in SalvCKO hearts after myocardial infarction ( Fig. 2d, e ). Category I, observed in 10% of SalvCKO cohort (n = 1 of 10), recovered most left ventricle cardiomyocytes. Category II, observed in 80% of SalvCKO hearts (n = 8 of 10), had an equal amount of fibrotic and cardiomyocyte area in the left ventricle. Category III, observed in 10% of SalvCKO hearts (n = 1 of 10), had few left ventricle cardiomyo cytes with a remodelled scar ( Fig. 2d-f ). The relationship between fibrosis and function was described by a secondorder polynomial, sug gesting that fibrosis is tolerated to maintain cardiac function ( Fig. 2g ). Three weeks after myocardial infarction, all hearts had left ventricle infarcts (Extended Data Fig. 3 ). At two time points, hearts were collected 1 week before echocardiography for histopathology. We discuss those time points as a 2 week range (that is, 4-5 and 6-7 weeks after myocardial infarction). There were no differences between groups at 4-5 weeks and 6-7 weeks after myocardial infarction ( Fig. 2b , c, f and Extended Data Figs 4 and 5). At 6 weeks after myocardial infarc tion, Myh7, Nppa, and Nppb, associated with adult cardiomyocyte remodelling, were upregulated in control ischaemic heart failure but not SalvCKO (Extended Data Fig. 6a ).
SalvCKO hearts at 6 weeks after myocardial infarction had a three fold increase in border zone capillary density and increased endothelial markers isolectin B4 and CD31 compared with controls (Extended Data Fig. 6b-e ). Cardiomyocyteenriched translating ribosomal affinity purification (TRAP) RNA revealed increased vasculogenesis genes encoding angiopoietins, fibroblast growth factors, and vascular endothelial growth factors in cardiomyocytes of SalvCKO hearts with myocardial infarction (Extended Data Fig. 6f ).
We found SalvCKO hearts had 2-3% cardiomyocyte 5 ethynyl2´deoxyuridine (EdU) incorporation at 4 and 6 weeks after myocardial infarction and approximately 1% at 9 weeks after myocar dial infarction ( Fig. 2k , l). Phosphohistone H3 immunofluorescence revealed Mphase cardiomyocytes 9 weeks after myocardial infarc tion in SalvCKO mice with myocardial infarction (Fig. 2m , n). Hence, cardiomyocyte cellcycle entry was diminished in SalvCKO mouse hearts at 9 weeks after myocardial infarction as cardiomyocytes repaired the tissue defect.
Lineage tracing using the αMHC-mcm transgene revealed mosaic labelling of border zone cardiomyocytes ( Fig. 2o ). At 4 weeks after myocardial infarction, the border zone had equivalent numbers of GFPpositive cardiomyocytes in controls (33 ± 7%) and SalvCKO (22 ± 2%) ( Fig. 2o , p). At 9 weeks after myocardial infarction, GFP positive border zone cardiomyocytes were enriched in SalvCKO (control myocardial infarction 41 ± 6%, SalvCKO myocardial infarction 91 ± 4%) ( Fig. 3o , p), indicating that most new, reparative border zone cardiomyo cytes are derived from preexisting cardiomyocytes rather than Myh6negative cardiac stem cells that would be GFPnegative. Cardiomyocyte crosssectional area was reduced, suggesting a more primitive phenotype, in SalvCKO mice at 9 weeks after myocardial infarction 14 (Fig. 2q ).
We sequenced total RNA and TRAP RNA from border zone 6 weeks after myocardial infarction (Extended Data Fig. 7a-d ). Total RNA revealed upregulated genes (n = 932) in SalvCKO border zone were involved in oxidative phosphorylation, RNA processing, stress Fig. 8a ). SalvCKO border zone downregulated genes (n = 792) included developmental genes, glycolytic metabolism genes, and connective tissue genes including profibrotic genes such as Tgfbr1, Ctgf, and Pdgfrδ ( Fig. 3d and Extended Data Fig. 8a) 15, 16 .
Comparison of TRAP sequencing (TRAPseq), enriched for cardio myocyte translating RNA ( Fig. 3e , f), with total RNAseq revealed that TRAPseq was enriched for cardiomyocyte genes and depleted of noncardiomyocyte genes ( Fig. 3g -i and Extended Data Fig. 8b ). Nontranslated LncRNAs were depleted from TRAPseq ( Fig. 3i and Extended Data Fig. 8b ). Comparison of total RNAseq with TRAPseq revealed total RNA and TRAPseq groups clustered separately ( Fig. 3j ). SalvCKO myocardial infarction TRAPseq clustered closely to control sham TRAPseq data, revealing that Hippodeficient cardiomyocytes expressed a genetic program similar to control shams ( Fig. 3j ).
We compared TRAPseq of control after myocardial infarction and control sham to determine changes in cardiomyocyte gene expression during ischaemic heart failure after myocardial infarction (Extended Data Fig. 8c -f). One upregulated category was peptide metabolic processes including Akt1, which exacerbates heart failure when chroni cally expressed 17 (Extended Data Fig. 8d , f). Genes that respond to reactive oxygen species, such as GstP1 and Gpx3, were upregulated as was Clusterin, known to be upregulated in human heart failure 18 . Another upregulated gene category, actinfilamentbased process, is consistent with observations that cytoskeletal components are upregu lated in human heart failure 19 . Downregulated gene categories included chromatin organization and blood vessel development, consistent with known gene expression changes in heart failure 20, 21 (Extended Data Fig. 8e , f). Genes involved in organelle fission, such as mitochondrial fission, were downregulated. Disruption of mitochondrial fission and fusion can lead to heart failure 22 (Extended Data Fig. 8e, f) .
We compared TRAPseq between SalvCKO and control hearts after myocardial infarction (Fig. 3f ). Upregulated genes (n = 365) included cell cycle genes, consistent with previous studies ( Fig. 3k and Extended Data Fig. 8g) 8, 9 . Other upregulated genes included genes involved in heart contraction, heart growth, and cellular response to stress, suggesting that SalvCKO cardiomyocytes were recovering the mature car diomyocyte phenotype with an effective stress response. Downregulated genes (n = 261) in SalvCKO cardiomyocytes after myocardial infarction included translation, protein metabolism including the ubiquitinproteosome pathway, and inflammation ( Fig. 3l and Extended Data Fig. 8g ), indicating that inflammation and misfolded protein response were more effectively resolved in SalvCKO myocardial infarction.
Park2, a Yap target gene, was upregulated in SalvCKO TRAPseq (Fig. 3m) 9 . Park2 encodes a ubiquitin ligase involved in mitochon drial quality control, a surveillance mechanism to recycle damaged mitochondria 23 . Park2 is recruited to damaged mitochondria to direct mitochondria into mitophagy pathway that salvages damaged mitochondria. Park2 protein levels are reduced in human heart failure (Fig. 4a, b and Extended Data Fig. 9a-c) . Moreover, deletion of Park2 in adult mice results in dilated cardiomyopathy after myocardial infarction 24 . Similar to Yap, Park2 is required for cardiac regeneration at postnatal day 1 (P1) (Extended Data Fig. 9d -i) 25 .
We tested whether Park2 was required for regeneration in P8 SalvCKO 8 . After P8 myocardial infarction, SalvCKO had higher mito chondrial DNA content and increased Park2 protein levels (Extended Data Fig. 10a, b ), suggesting that mitochondrial quality control is more active in SalvCKO hearts. Park2 was required for recovery of myocardial function in SalvCKO hearts after P8 myocardial infarction (Extended Data Fig. 10c-g) . Interestingly, although myocardial function was reduced, fibrosis did resolve in SalvCKO;Park2 −/− hearts, indicating a myocardialautonomous requirement for Park2 in SalvCKO neonatal hearts (Extended Data Fig. 10c, g) .
Park2 was required for cardiac function recovery in adult ischaemic heart failure ( Fig. 4c-g) . Compared with SalvCKO mice, double mutant SalvCKO;Park2 −/− mice did not recover contractile function (Fig. 4c,d ). However, unlike SalvCKO adult hearts and SalvCKO;Park2 −/− neonatal hearts (Extended Data Fig. 10c ), scar failed to resolve in SalvCKO;Park2 −/− adult hearts, revealing a differential requirement for Park2 in neonatal versus adult fibrosis resolution ( Fig. 4e-g) . 
We engineered a viral vector to knockdown Salv in cardiomyocytes (Fig. 4h, i) . Direct myocardial viral injection at the time of myocardial infarction or systemic viral injection 3 weeks after myocardial infarc tion resulted in improved cardiac function and cell cycle induction ( Fig. 4j-o) . Hippo pathway inhibition, genetically or with gene therapy, results in an effective stress response in ischaemic heart failure with organ failure reversal.
Since Hippo signalling is upregulated in human ischaemic heart failure, Hippo pathway inhibition may have a therapeutic benefit for patients with ischaemic heart failure. We identified cardiomyocyte directed, noncellautonomous injury responses that improve vascular perfusion. New cardiomyocytes, derived from preexisting cardiomyo cytes, direct recovery of a border zone microvasculature by expressing vesselpromoting factors including fibroblast growth factors that are protective against cardiac damage 26-28 . Reversal of ischaemic heart failure requires a proliferative response and injury resistance since newly generated cardiomyocytes must withstand both mechanical and hypoxic stress. Atrisk cardiomyocytes also probably benefit from Hippo pathway inhibition.
Our data provide insight into Park2 function in cardiac regeneration. In addition to mitochondrial quality control, Park2 functions in mito chondrial maturation and in fetaltoadult metabolic transition 29 . Park2 is essential for neonatal regeneration and for cardiac repair in nonregenerative P8 SalvCKO hearts and in ischaemic heart failure. In P8 SalvCKO hearts, Park2 deletion was detrimental to cardiac function, but dispensable for fibrosis resolution. In contrast, in adult ischaemic heart failure, both cardiac function and fibrosis resolution were impaired in SalvCKO;Park2 −/− mice. Park2 requirements in car diomyocyte function and fibrosis resolution are an area of future study.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Proc. Natl Acad. Sci. USA 110, 13839-13844 (2013 350, aad2459 (2015) .
Supplementary Information is available in the online version of the paper. To achieve recombination of floxed alleles in the adult mice, tamoxifen dissolved in peanut oil was administered via intraperitoneal injection at a dose of 1 mg per day for 4 days beginning 3 weeks after myocardial infarction. No tamoxifen was administered to the mice in the P1 experiments. To achieve recombination of the floxed alleles in the P8 mouse experiments, tamoxifen was administered at P7, P8, P9, and P10, at 0.5 mg per day dissolved in peanut oil, as previously described 8 .
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All mouse procedures were performed in accordance with institutional and governmental guidelines, and approved by the Baylor College of Medicine Institutional Animal Care and Use Committee. Surgical procedures. Model of heart failure in adult mice. To induce myocar dial infarction in 8 to 10weekold mice, we permanently ligated the left anterior descending artery as previously described 8 . Briefly, mice were anaesthetized with 2% isoflurane and then intubated. We exposed the heart by performing a thora cotomy through the fourth or fifth intercostal space and tied an 80 nylon suture around the left anterior descending artery. The mice were allowed to recover for 3 weeks, and then heart function was analysed by using echocardiography. Because the clinical definition of heart failure is a 20% reduction in left ventricular ejection fraction as indicated on echocardiography (that is, from > 50% ejection fraction to < 40% ejection fraction in humans) 34 , only mice with > 20% decrease in left ventricular ejection fraction were included in the study 13 . Our observed rates of survival (64%) and inclusion (70%) were consistent with those previously reported (50-60% and 54-92%, respectively) 13, 34, 35 .
Model of myocardial infarction in early and late neonatal mice. To induce myocardial infarction in neonatal mice, we permanently ligated the left anterior descending artery on P1 or P8, as previously described 8 . Briefly, mice were anaes thetized with hypothermia, the heart was exposed via thoracotomy through the fourth or fifth intercostal space, and an 80 nylon suture was tied around the left anterior descending coronary artery. Echocardiography. Cardiac function was determined by echocardiography (VisualSonics, Vevo 2100, 40 MHz 550S probe). After alignment in the transverse Bmode with the papillary muscles, cardiac function was measured on Mmode images.
Injury regions. Cardiac tissue regions used for RNA or image characterization are described as whole heart, ischaemic zone (left ventricle free wall), border zone (left ventricle anterior and posterior walls), or distal zone (interventricular septum). Histological analysis. Whole hearts were fixed with 10% formalin, embedded in paraffin, and sectioned at 7μ m intervals. Each slide had 10 sections, which started at the apex and ended at the suture ligation site (approximately 50 slides). Every fourth slide was stained with Masson's trichrome to identify areas of fibrosis.
To determine scar size, we examined serial sections from the apex to the ligation suture site and calculated the average percentage fibrosis of the area and the midline circumference around the left ventricle 36 . To quantify cardiomyocytes, we used PCM1 immunostaining and methods as described 37 . Immunofluorescence experiments. To assess cell cycle entry, we added thymidine analogues to the drinking water for a duration of 4 days before dissection. The analogue 5iodo2′ deoxyuridine (IdU; 0.2 g l −1 , MP Biomedical, 0210035701) was used at the time point of 3 weeks after myocardial infarction before tamoxifen delivery. The analogue EdU (0.2 g l −1 , Santa Cruz, sc284628A) was used for the time points at 4, 6, and 9 weeks after myocardial infarction. Immunofluorescence experiments were performed on formalinfixed and paraffinembedded sections or on fresh frozen optimum cutting temperatureembedded sections. The stains and antibodies used for these experiments included a ClickiT EdU kit, IdU staining (IdU crossreactive BrdU antibody, BD Biosciences, 347580), mTmG lineage trace (endogenous mTomato and mGFP fluorescence), isolectin B4 (Vector Labs, FL1201), CD31 antibody (Pecam, BD Pharmingen, 550274), PCM1 (Sigma, HPA023370), cTnT (ThermoFisher, MS295), wheat germ agglutinin (Vector Labs, RL1022), and pH H3 (Cell Signaling, 9701).
Linage tracing was done using the ROSA mT/mG reporter at 4 and 9 weeks after myocardial infarction in the border zone. A full dose of tamoxifen was adminis tered, and mosaicism of the reporter was observed in the border zone. Mosaicism was not observed in the distal zone. We assumed this was because of the variability of drugincluded Cre activity because of the poor border zone vascularity. The time point at 4 weeks after myocardial infarction was used as a baseline to determine Cre activity in the border zone. RNA. Total RNA. Using trizol reagent, we isolated total RNA from the nonfibrotic myocardium (interventricular septum, anterior and posterior free wall) below the ligation suture.
TRAP RNA. The TRAP method utilizes an inducible haemagglutinin (HA) epitopetagged ribosomal allele for the Cremediated cellspecific isolation of RNA 38 . By crossing this allele into the SalvCKO background and then performing TRAPseq, we enriched for mRNAs that were loaded onto ribosomes in cardio myocytes and determined the cardiomyocyte translating RNA profile. We quickly excised the whole heart from each mouse and obtained the left ventricle anterior and posterior free walls (the myocardial border zone) below the ligation suture to isolate ribosomalassociated cardiomyocytespecific RNA. The tissue was homo genized on ice in 1 ml of supplemented homogenization buffer (1% NP40, 0.1 M KCl, 0.05 M Tris, 0.012 M MgCl 2 , 0.1 mg ml −1 cyclohexamide, protease inhibitors, RNAsin, 0.01 M DTT). The samples were centrifuged, and the supernatants were incubated at 4 °C for 4 h with the primary HAantibody (Cell Signaling, 3724) and then overnight with proteinG magnetic beads (Pierce, 88847). Beadantibody RNA isolation was performed on the homogenate, which was washed with a highsalt buffer (1% NP40, 0.3 M KCl, 0.05 M Tris, 0.012 M MgCl 2 , 0.1 mg ml −1 cyclohexamide, 0.01 M DTT). In samples with no expression of the Rpl22 HA transgene, we recovered less than 1% of the total input RNA; therefore, we assumed that the RNA isolation was highly specific.
Quantitative PCR. Transcript levels were quantified by using qPCR. First strand synthesis was performed by using iScript reverse transcription super mix for qPCR (BioRad, 1708841); then, qPCR was performed by using iTaq Universal SYBR Green super mix (BioRad, 1725121). All qPCR primers are listed in Supplementary Table 1 .
RNAseq library preparation and data analysis. To isolate mRNA from total RNA and TRAP RNA samples, we used a Dynabeads mRNA DIRECT Micro kit. ERCC Ex Fold RNA SpikeIn control mixes were added before mRNA purification. Ion torrent RNAseq libraries were prepared with an Ion Total RNAseq kit v2 for wholetranscriptome libraries. RNA sequencing was performed by using the Ion Proton system for nextgeneration sequencing. Reads were mapped to the mouse genome (mm10) and read counts quantified using STAR (version 2.5). Differentially expressed genes were detected using R package DESeq2 with the following parameters: threshold P ≤ 0.05, fold change ≥ 0.5, and false detection rate ≤ 10%. GO analysis was performed on differentially expressed genes (P < 0.05) with the Metascape online platform, and annotation clusters with terms that had P ≤ 0.05 were included.
We compared our TRAP versus total RNA analysis with the cardiomyocyte and noncardiomyocyte isolation data set (GSE49906) 39 Corresponding author(s): James Martin
Initial submission Revised version Final submission
Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity. 
Data exclusions
Describe any data exclusions. Mice that did not show >20% decrease in left ventricular ejection fraction were excluded from the study.
Replication
Describe whether the experimental findings were reliably reproduced.
All attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
A block randomization scheme was used to assign animals to groups on a rolling admissions basis to obtain adequate samples for each time point and each experiment.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Mice were assigned unique identifiers to blind experimenters to genotypes.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
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A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
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